Trump Administration Launches Commission to Review Children’s Medication Impact

ATLANTA — The Trump Administration has unveiled an Executive Order that may reshape how medications are regulated for children. Part of this order mandates a committee to assess the long-term impact of antidepressants and stimulants on young patients.

Parents and Doctors Watch in Tension

Local doctors and parents are closely monitoring this new initiative. Some are apprehensive about potential restrictions on their children’s access to life-changing medications, while others view it as an opportunity to ensure the safety and efficacy of these drugs over the long term.

“There is fear, right? We think about, you know, will I lose access to these resources?” shared Jewell Gooding, a mother deeply involved in metropolitan Atlanta’s mental health advocacy community through the non-profit organization Silence the Shame.

Gooding’s Perspective

Gooding is a mother to two children, one with anxiety disorder and the other with attention deficit hyperactivity disorder. Medication has been crucial in managing their conditions effectively. “Medication does play a key role in their success,” she emphasized.

[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]

Establishment of the Commission

The newly established commission, dubbed the “Make America Healthy Again Commission” by the Trump Administration, is led by Secretary of the Department of Health and Human Services Robert F. Kennedy Jr., who serves as Chair. The Assistant to the President for Domestic Policy will direct the commission’s operations.

The commission’s mandate extends to evaluating the impact of medical treatments on chronic diseases. One of its primary directives is to assess the widespread use and potential risks associated with selective serotonin reuptake inhibitors (SSRIs), antipsychotics, mood stabilizers, stimulants, and weight-loss drugs.

Medical Expert Weighs In

Dr. Tony Reyes, Director of Behavioral Health at Wellstar Cobb Hospital, offers an expert perspective on the drugs under scrutiny. He highlights that while there are always risks associated with medication, the benefits often outweigh the drawbacks.

“If I have a child or adult who is experiencing severe depression, it is likely their benefit is going to outweigh the risk at that point in time,” Dr. Reyes explained.

Side Effects and Precautions

Dr. Reyes mentions several potential side effects of SSRIs, including stomach issues. He also notes that in rare cases, SSRI use has been linked to an increase in suicide ideation, warranting warnings from regulatory bodies.

Advice for Concerned Parents

Gooding encourages parents with concerns about medications to maintain open lines of communication with healthcare providers. “Slow things down,” she advises. “Monitor relevant information and pay attention. Have conversations with your legislators.”

Those interested in reviewing the full executive order can visit this link.

[SIGN UP: WSB-TV Daily Headlines Newsletter]

Conclusion

The debate around children’s medication access and safety is complex and multifaceted. While the commission’s work promises to shed light on long-term effects, its impact remains to be seen. It is vital for parents to stay informed and consult with healthcare professionals.